Mental Health
Latest News
FDA approves intranasal esketamine for refractory major depressive disorder
Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...
Conference Coverage
Eczema increases the risk of impaired mental health among children
WASHINGTON – Many children with eczema and impaired mental health may not be receiving appropriate psychological...
Audio
Masterclass: Marlene Freeman on treating bipolar disorder in women
Dr. Freeman shares preliminary data on the impact of exposure to atypicals from the National Pregnancy Registry at Mass General.
News
How Are Schizophrenic Patients Treated After Myocardial Infarction?
Researchers find that patients with schizophrenia may be lacking needed cardiology treatment.
Conference Coverage
Parsing the fine points of anxiety
LAS VEGAS – Many trials of anxiety medications are of short duration and therefore lack evidence of long-term improvement, according to Dr. Robert...
News
Antidepressants may be best add-on to antipsychotics in schizophrenia
“The possibility that adjunctive use of gabapentin is associated with increased risk of death raises a serious concern.”
News
Teens likely to mimic parents’ opioid use
Interventions that target parental use and emphasize positive parenting may lower adolescent opioid use.
Conference Coverage
Alcohol abstinence questioned as addiction treatment goal
BONITA SPRINGS, FLA. – Data suggest that patients often achieve significant improvements by reducing alcohol intake short of abstinence.
Original Research
VA Forges a Historic Partnership with the National Shooting Sports Foundation and the American Foundation for Suicide Prevention to Prevent Veteran Suicide
The collaboration seeks to reduce the nearly 7 in 10 US veteran suicides that result from firearms.
News
FDA panels back intranasal esketamine for refractory depression
ROCKVILLE, MD –